Use of Recombinant Factor VII as a Prophylactic Therapy for Adolescent Females With Heavy Menstrual Bleeding

Conditions: Assessing the Bleeding Profile and the Quality of Life of the Enrolled Patients Before and 1 Year After Drug Intervention Interventions: Drug: Proph7 Sponsors: Minia University Hospital Completed

Source: ClinicalTrials.gov - February 14, 2024 Category: Research Source Type: clinical trials